title: Market watch: Are orphan drug companies the pick of the pharmaceutical industry?
authors.affiliation: KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Herestraat 49, 3000 Leuven, Belgium, and at Deloitte Financial Advisory Services (FAS), Berkenlaan 8a Diegem, 1831 Belgium.
authors.forename: Thomas
authors.initials: T
authors.lastname: Morel
authors.affiliation: Deloitte FAS, Diegem, Belgium.
authors.forename: Cedric
authors.initials: C
authors.lastname: Popa
authors.affiliation: KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium.
authors.forename: Steven
authors.initials: S
authors.lastname: Simoens
mesh_terms: D016527:Drug Costs / Q000639:trends*; D006801:Humans; D007449:Investments / Q000191:economics*; D009965:Orphan Drug Production / Q000191:economics*